LAV ADVANCED MANAGEMENT COMPANY LIMITED
LAV ADVANCED MANAGEMENT COMPANY LIMITED is a Seed, Series A, Series B and Series C+ fund in global investing in Healthcare, biomedical, pharmaceuticals, biotechnology and pharmaceutical.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- Healthcare, biomedical, pharmaceuticals, biotechnology, pharmaceutical
- Invests in
- global
- Actively investing
- Yes
- Founded
- 2008
- Assets under management
- $1.4B
- Website
- lavfund.com
Check size not disclosed
Thesis
LAV Advanced Management Company Limited is a global biomedical venture capital firm established in 2008 and operating independently since 2011. They prioritize "quality science" and "bet on people" and "products" with the potential to become industry best-sellers within 5-10 years, explicitly avoiding low-quality products or "quick flip" investments. LAV operates globally with offices in Hong Kong, Shanghai, and Palo Alto. The firm manages $1.4 billion in AUM across its funds, including Lilly Asia Ventures Fund III, L.P. ($100M offering), LAV Biosciences Fund IV LP, and LAV Biosciences Fund III, L.P. LAV is registered as an Exempt Reporting Adviser (ERA) with the SEC. While specific team and portfolio details are not disclosed, their focus is on the biotechnology, pharmaceutical, and healthcare sectors. The firm aims to be a trusted, long-term partner for entrepreneurs.
Common questions
Does LAV ADVANCED MANAGEMENT COMPANY LIMITED invest at the Seed stage?
Yes. LAV ADVANCED MANAGEMENT COMPANY LIMITED lists Seed, Series A, Series B and Series C+ among the stages it invests in.
Where does LAV ADVANCED MANAGEMENT COMPANY LIMITED invest?
LAV ADVANCED MANAGEMENT COMPANY LIMITED invests in global.